Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086658
Status:
COMPLETED
Last Update Posted:
2020-05-05
First Post:
2004-07-07
Brief Title:
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes HES
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2006-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-07
First Submit QC Date:
July 8 2004
Study First Post Date:
2004-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-01
Last Update Post Date:
2020-05-05
Last Update Post Date Type:
ACTUAL